- Home
- CTNM vs CYH Comparison
CTNM vs CYH Comparison
Compare CTNM & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNM | CYH |
|---|---|---|
| Founded | 2009 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Hospital/Nursing Management |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.4M | 521.4M |
| IPO Year | 2024 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CTNM | CYH |
|---|---|---|
| Price | $13.90 | $3.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $19.00 | $3.28 |
| AVG Volume (30 Days) | 512.7K | ★ 1.6M |
| Earning Date | 05-13-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.46 | ★ 196.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,485,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.08 | $2.39 |
| 52 Week High | $16.91 | $4.43 |
Technical Indicators
Market Signals| Indicator | CTNM | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 48.92 |
| Support Level | $13.86 | $3.21 |
| Resistance Level | $14.96 | $3.29 |
| Average True Range (ATR) | 0.95 | 0.22 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 16.25 | 23.30 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.